Home
Country Websites
Contact
Sitemap
Search
Submit
Value through Innovation
19 May 2012
NEWS
VISION AND MISSION
CONGRESSES
LET'S LEARN
LET'S THINK
LET'S INVESTIGATE
THE WHITE ROOM
HOME
Site Map
Page content
jump to main navigation
jump to meta navigation
NEWS
VISION AND MISSION
CONGRESSES
Congresses 2012
TAT 2012
PCGOC 2012
ELCC 2012
Congresses 2013
Virtual Symposia
LET'S LEARN
Cancer
What causes cancer
Can cancer be prevented
How is cancer treated
Lung Cancer
What is lung cancer
What is the prevalence of lung cancer
What are the main types of lung cancer
What are the risk factors of lung cancer
What are the signs and symptoms of lung cancer
How is lung cancer diagnosed
What are the available treatment options of lung cancer
Breast Cancer
What is Breast Cancer
What is the prevalence of breast cancer
What are the risk factors for breast cancer
What are the signs and symptoms of breast cancer
How is breast cancer diagnosed
What are the available treatment options for breast cancer
Patient selection procedures for breast cancer treatment
HER 2 positive breast cancer
New treatment directions in breast cancer
Afatinib in breast cancer
Ovarian Cancer
What is ovarian cancer
What is the prevalence of ovarian cancer
What are the risk factors of ovarian Cancer
What are the signs and symptoms of ovarian cancer
How is ovarian cancer diagnosed
What are the available treatment options
Head & Neck Cancer
What is head and neck cancer
What is the prevalence of head and neck cancer
What are the risk factors for head and neck cancer
What are the signs and symptoms of head and neck cancer
How is head and neck cancer diagnosed
What are the available treatment options for head and neck cancer
New treatment directions in head and neck cancer
New treatment directions in head and neck cancer
Targeted Therapies in Action
Signal Transduction Inhibition
Angiogenesis Inhibiton
Cell-Cycle Inhibiton
Signal-Transduction Inhibition – afatinib (BIBW 2992)
Angiogenesis inhibition – Vargatef (BIBF1120)
Cell cycle kinase inhibition – volasertib (BI 6727)
BI in Oncology
Boehringer Ingelheim's commitment to cancer
Research and development in cancer treatments
Research focus at Boehringer Ingelheim
R & D in oncology: clinical trial overview
Guidelines
Guidelines
Glossary of terms
LET'S THINK
ePatCare™
View or Create Patient Case
Select Patient Case
Show Patient Case
Create Patient Case
Edit individual patient data
Implement test questions
Patient Cases
LET'S INVESTIGATE
Lung Cancer
Ovarian Cancer
Breast Cancer
Head & Neck Cancer
THE WHITE ROOM
back to top
Accessibility statement
Homepage
Sitemap
Search
Contact
Print